ASTRAZENECA PLC DL-,25/ GB0009895292 /
2024-03-28 5:35:58 PM | Chg. -0.25 | Volume | Bid2024-03-28 | Ask2024-03-28 | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
125.95EUR | -0.20% | 22,850 Turnover: 2.88 mill. |
-Bid Size: - | -Ask Size: - | 193.91 bill.EUR | - | - |
GlobeNewswire
03-28
HUTCHMED Announces Savolitinib sNDA Accepted in China for Treatment-Naïve or Previously Treated Pati...
GlobeNewswire
03-20
FundaMental Pharma Appoints Industry Veteran Dr. Lorenz Mayr as Non-Executive Director
GlobeNewswire
03-19
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Fusion Phar...
GlobeNewswire
02-26
FibroGen Regains All Rights to Roxadustat from AstraZeneca in the United States and Other AstraZenec...
GlobeNewswire
02-05
Yiviva Announces Memorandum of Understanding with AstraZeneca to Develop Platforms, Technologies, an...